G Peluso|L Mansi - JoVE Visualize

Showing results (201-210 of 213) with videos related to

Pageof 22

Sort By:

Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2013

DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinomaS Kim, M Jary, L Mansi, et al.

Transplantation Proceedings|January 19, 2019

Ethical Issues in the Use of Suboptimal Kidneys for Transplants: An Italian Point of ViewP Incollingo, G Peluso, L Pelosio, et al.

Journal of Sports Sciences|October 20, 2025

Skill progression pathways and head kinematics in men's artistic gymnasticsGiovanny A Romero A, N Stewart Pritchard, Kambrie M Brandt, et al.

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|June 11, 1999

Evidence of exercise-induced myocardial ischemia in patients with primary aldosteronism: the Cross-sectional Primary Aldosteronism and Heart Italian Multicenter StudyC Napoli, F Di Gregorio, M Leccese, et al.

The Lancet. Oncology|June 1, 2005

Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trialAndreas Polychronis, H Dudley Sinnett, Dimitri Hadjiminas, et al.

British Journal of Cancer|February 23, 1999

Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigenJ N Primrose, H Bleiberg, F Daniel, et al.

Breast Cancer Research and Treatment|June 19, 2010

Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group studyJanine L Mansi, Ann Yellowlees, Julian Lipscombe, et al.

Frontiers in Health Services|September 18, 2023

Toward a more comprehensive understanding of organizational influences on implementation: the organization theory for implementation science frameworkSarah A Birken, Cheyenne R Wagi, Alexandra G Peluso, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005

Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group studyT R Jeffry Evans, Ann Yellowlees, Elizabeth Foster, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2004

A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in the neo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trialI E Smith, R P A'Hern, G A Coombes, et al.

Pageof 22

Showing results (201-210 of 213) with videos related to

Sort By:

Pageof 22

Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2013

DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinomaS Kim, M Jary, L Mansi, et al.

Transplantation Proceedings|January 19, 2019

Ethical Issues in the Use of Suboptimal Kidneys for Transplants: An Italian Point of ViewP Incollingo, G Peluso, L Pelosio, et al.

Journal of Sports Sciences|October 20, 2025

Skill progression pathways and head kinematics in men's artistic gymnasticsGiovanny A Romero A, N Stewart Pritchard, Kambrie M Brandt, et al.

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|June 11, 1999

Evidence of exercise-induced myocardial ischemia in patients with primary aldosteronism: the Cross-sectional Primary Aldosteronism and Heart Italian Multicenter StudyC Napoli, F Di Gregorio, M Leccese, et al.

The Lancet. Oncology|June 1, 2005

Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trialAndreas Polychronis, H Dudley Sinnett, Dimitri Hadjiminas, et al.

British Journal of Cancer|February 23, 1999

Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigenJ N Primrose, H Bleiberg, F Daniel, et al.

Breast Cancer Research and Treatment|June 19, 2010

Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group studyJanine L Mansi, Ann Yellowlees, Julian Lipscombe, et al.

Frontiers in Health Services|September 18, 2023

Toward a more comprehensive understanding of organizational influences on implementation: the organization theory for implementation science frameworkSarah A Birken, Cheyenne R Wagi, Alexandra G Peluso, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005

Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group studyT R Jeffry Evans, Ann Yellowlees, Elizabeth Foster, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2004

A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in the neo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trialI E Smith, R P A'Hern, G A Coombes, et al.

Pageof 22